Albert David Ltd

₹849.35▼ -2.55%28 Sept

📊 Stock Analysis

Market Data

Market Cap₹484.74 Cr.

52W High₹925

Current Price₹849.35

52W Low₹581.3

Down from 52W High8.2 %

Face Value₹10

Performance

ROCE7.26 %

ROE5.76 %

EPS (TTM)₹56.07

EPS Prev Qtr₹-37.56

EPS Last Year₹-5.79

EBITDA Qtr₹8.35 Cr.

Book Value₹685

Financial Health

Debt/Equity0.07

Debt/Profit1.26

Total Assets₹519.133 Cr.

Dividend Yield0.59 %

Promoter Holding62.24 %

Earning Power3.29 %

Valuation

Stock P/E21.49

Industry P/E33.81

Price to Book1.24

Price to Sales1.33

Graham Number₹780.53

Key Metrics

Face Value

₹10

About Albert David Ltd

Healthcare · Pharmaceuticals

Albert David Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹10. Market cap ₹484.74 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.51	₹4,41,477.63 Cr	0.87%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	86.48	₹2,53,031.38 Cr	0.31%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	77.67	₹1,85,216.32 Cr	0.78%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	27.01	₹1,20,897.46 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.28	₹1,12,201.64 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	99.31	₹1,08,698.22 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Dr Reddys Laboratories Ltd	-	31.6	₹1,02,039.12 Cr	0.65%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Mankind Pharma Ltd	-	49.29	₹1,00,752.43 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Aurobindo Pharma Ltd	-	26.56	₹97,814.24 Cr	0.24%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.64	₹94,274.49 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	36.67	₹65,922.11 Cr	0.11%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	28.65	₹61,804.34 Cr	1.03%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	110.29	₹61,113.53 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.22	₹56,860.69 Cr	1.78%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Glaxosmithkline Pharmaceuticals Ltd	-	46.73	₹49,091.33 Cr	1.97%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ipca Laboratories Ltd	-	36.13	₹48,712.48 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	83.03	₹47,949.68 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Gland Pharma Ltd	-	42.26	₹47,764.08 Cr	0.69%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ajanta Pharma Ltd	-	38.87	₹44,109.77 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	87.24	89.93	85.86	101.34
↳ QoQ Growth	-	+3.1%	-4.5%	+18.0%
Expenses	86.93	81.53	85.83	92.99
Operating Profit	0.31	8.4	0.03	8.35
OPM %	0.36%	9.34%	0.03%	8.24%
Other Income	-2.14	12.4	-24.84	27.96
Interest	0.75	0.9	0.43	0.52
Depreciation	2.23	2.42	2.72	2.29
EBITDA	2.54	10.82	2.75	10.64
EBITDA Margin %	2.91%	12.03%	3.2%	10.5%
Profit Before Tax	-2.58	19.9	-25.23	35.79
Tax %	-27.91%	23.12%	15.06%	10.62%
Net Profit	-3.3	15.3	-21.43	32
↳ QoQ Growth	-	+563.6%	-240.1%	+249.3%
EPS	-5.79	26.81	-37.56	56.07

Balance Sheet

	Mar 2025	Mar 2026
Equity Capital	5.71	5.7072
Reserves	386.78	385.8291
Borrowings	12.32	28.48
Other Liabilities	106.61	99.12
Total Liabilities	511.42	519.1328
Fixed Assets	97.71	99.6507
CWIP	1.73	20.7655
Investments	260.16	243.29
Other Assets	151.82	155.43
Total Assets	511.42	519.1328

Cash Flows

	Mar 2026
Cash from Operating Activity	-7.6585
Cash from Investing Activity	-4.3998
Cash from Financing Activity	11.9216
Net Cash Flow	-0.1367

Shareholding Pattern

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters %	62.24%	62.24%	62.24%	62.24%
FIIs %	0.6%	0.6%	0.58%	0.57%
DIIs %	1.66%	1.65%	1.65%	1.63%
Public %	27.72%	27.36%	27.45%	28.05%
No. of Shareholders	14,666	13,967	13,555	13,155

Major Shareholders (>1%)

As of 2026-06-30View all shareholders →

Tools